|
|
|
|
| LEADER |
00000cam a2200000Mu 4500 |
| 001 |
EBOOKCENTRAL_on1257084780 |
| 003 |
OCoLC |
| 005 |
20240329122006.0 |
| 006 |
m o d |
| 007 |
cr ||||||||||| |
| 008 |
210619s2021 xx o ||| 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|c EBLCP
|d LOA
|d REDDC
|d OCLCF
|d OCLCQ
|d OCLCO
|d OCLCL
|
| 020 |
|
|
|a 9781681087788
|
| 020 |
|
|
|a 1681087782
|
| 029 |
1 |
|
|a AU@
|b 000072106311
|
| 035 |
|
|
|a (OCoLC)1257084780
|
| 050 |
|
4 |
|a RA644.C67
|b .K373 2021
|
| 082 |
0 |
4 |
|a 616.2414
|2 23
|
| 049 |
|
|
|a UAMI
|
| 100 |
1 |
|
|a Karcioglu, Ozgur.
|
| 245 |
1 |
0 |
|a Demystifying COVID-19
|h [electronic resource].
|
| 260 |
|
|
|a Sharjah :
|b Bentham Science Publishers,
|c 2021.
|
| 300 |
|
|
|a 1 online resource (413 p.)
|
| 500 |
|
|
|a Description based upon print version of record.
|
| 505 |
0 |
|
|a Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Preface -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- Contagion of the Pandemics: The Situation in the World -- FATALITY AND MORTALITY DIFFERENCES BETWEEN COUNTRIES -- WHICH COUNTRIES HAVE THE HIGHEST NUMBER OF CASES? -- TO NORMALIZE OR NOT TO NORMALIZE, IT IS THE MAIN QUESTION! -- CONTAGIOUSNESS OF CORONAVIRUS -- IN WHAT WAYS IS CORONAVIRUS TRANSMITTED? -- Where is The Contamination Happening? -- Is It Airborne? -- Air Conditioning + 1 Patient = 10 Patients: Who is Guilty? -- How is The Air Conditioner Cleaned? -- How Should We Clean Our Air Conditioner? -- CONCLUSION -- REFERENCES -- How Can a Country Defeat COVID-19? Value of R0, Rt and Re -- WHAT ARE R0, RT, AND RE? -- INCUBATION PERIOD -- PRINCIPLES OF SURVEILLANCE AND STRUGGLE WITH THE PANDEMIC: HOW COUNTRIES DIFFER FROM EACH OTHER? -- HOW EFFECTIVE IS HOME STAY, SOCIAL / INDIVIDUAL ISOLATION IN PREVENTING THE SPREAD OF COVID-19? -- BELGIUM HAS A VERY DIFFERENT CASE SITUATION -- HERD IMMUNITY AND THE 'SECOND WAVE' PROBLEM: MYTH OR TRUTH? -- IS THE 'ORDINARY CITIZEN' ALSO GUILTY? WHICH MISTAKES DID THEY DO IN THE PANDEMIC AND 'NORMALIZATION'? -- HOW DOES THIS DISEASE END? -- THE SPANISH FLU EXPERIENCES OF 1918: DOES HISTORY LIGHT OUR WAY? -- Why is It Called 'Spanish Flu'? -- Is It Different From Other Flu Syndromes? -- WHAT HAPPENED IN THE USA? -- Mass Graves Were Opened in The Usa in September 1918 Due To Massive Death Toll -- REFERENCES -- Comorbid Diseases and COVID-19: COPD, Smoking, Obesity, Diabetes, Cancer, and Kidney Failure -- THE RELATIONSHIP BETWEEN COVID-19 FATALITY RATE AND COMORBIDITIES -- PULMONARY DISEASES AND COVID-19 -- Could COVID-19 Infection also Cause COPD-AA? -- Are Patients with COPD or Asthma at High Risk for Contracting COVID-19?.
|
| 505 |
8 |
|
|a Are Patients with COPD at High Risk for Severe COVID-19 and Death? -- How are The Follow-up and Treatment of COPD and COPD-AA Cases During The Pandemics? -- Are Systemic Corticosteroids (CST) Used in COPD-AA During Pandemic? -- Are There Any Changes For Asthma Patients? -- How is an Asthma Attack Treated While Infected with COVID-19? -- Is the Use of Nebulizers Recommended in The Treatment of Asthma/COPD During The COVID-19 Outbreak? -- Does Smoking and COPD Development Alter Expression of ACE2 Receptors? -- Does Smoking Affect Clinical Course? -- Is Smoking also Effective in Influenza? -- Is COVID-19 More Severe in Smokers? -- What are The Key Findings of Systematic Reviews and Meta-analyzes with High Level of Evidence? -- What is "Smoker's Paradox" (SP), are There any Justifications? -- OBESITY AND COVID-19 -- Numerical Data showing the Relationship between Obesity and COVID-19 -- DIABETES AND COVID-19 -- In a Diabetic Patient Hospitalized in The COVID-19 Process, There will be 5 Essential Steps of Management -- CANCER AND COVID-19 -- Why are Cancer Patients More Disadvantaged in Terms of COVID-19? -- Are There any More Special Risk Groups among People with Cancer? -- Can Cancer be Diagnosed During The Pandemic Period, and can Interventions be Performed as Before? -- Are there Specific Difficulties in Diagnostic Interventions for COVID-19? -- Are There Specific Difficulties for Cancer Patients Regarding Care and Treatment? -- Is there any Difference Regarding the Psychological Conditions of Cancer Patients in this Period? -- THE RISK OF REACTIVE OR MAJOR DEPRESSION WILL BE FURTHER INCREASED -- What are the General Messages? -- RENAL FAILURE (RF), ACUTE KIDNEY INJURY (AKI) AND COVID-19 -- LUNG-KIDNEY AXIS (LKA): A NEW PATHWAY FOR KIDNEY DAMAGE? -- CONCLUSION -- REFERENCES -- Risks and Losses of Healthcare Workers in the Pandemic Era.
|
| 505 |
8 |
|
|a PHENOMENA PROVEN TO INCREASE THE RISK OF COVID-19 TRANSMISSION IN HCW -- Is COVID-19 Risky for HCW? -- How much Risk COVID-19 Impose on HCW? -- HEADLINES FROM VARIOUS COUNTRIES -- THE SITUATION IN TURKEY -- SITUATIONS INCREASING THE RISK OF INFECTION TO HCW -- Findings -- Precautions and Measures -- Personal Protective Equipment -- Sequence of Control Measures -- Infection Protection and Control Measures -- Psychosocial Problems in HCW During The Pandemics -- What kind of Interventions can be Pursued to Support The Resilience and Mental Health of Frontline HCW During The Pandemic? -- IS THERE ANY GOOD NEWS TO CONVEY? -- CONCLUSION -- REFERENCES -- What Kind of Disease is this? Signs and Symptoms, Predictors of Clinical Course and Management -- DO PATIENTS WHO ARE DIAGNOSED NECESSARILY HAVE SYMPTOMS? -- ASYMPTOMATIC AND SYMPTOMATIC... IS THERE A 3RD WAY? -- Can A Mild-looking Patient Worsen Quickly? -- WHICH MARKERS CAN WE USE TO PREDICT CLINICAL WORSENING? -- RADIOLOGICAL CRITERIA -- TYPICAL CASE -- HOW ARE COVID AND COUGH RELATED? -- Cough In Terms of Contagiousness -- Pharmacological Methods To Relieve Cough -- GASTROINTESTINAL COMPLAINTS AND FINDINGS IN THE COURSE OF COVID-19 -- CORONA FACTS: WHICH IS CORRECT? -- CONCLUSION -- REFERENCES -- Diagnosis of COVID-19: Which Tests To Do? Laboratory and Radiological Adjuncts To Recognition -- LABORATORY TESTS -- Cytokines and Related Findings -- Laboratory Values Can Also Highlight The Stages of The Disease -- Do Antibody Tests Give Accurate Results In The Early Period After Infection? -- CHEST IMAGING -- RADIOLOGICAL EXAMINATIONS -- Which Should We Choose? X-ray, CT, USG, or MR? -- CASE EXAMPLE AND TIME COURSE OF THE DISEASE -- CONCLUSION -- REFERENCES -- Cardiovascular Disease, Myocarditis, Infarctions, And COVID-19 -- KEY FINDINGS FROM DIFFERENT DATABASE STUDIES.
|
| 505 |
8 |
|
|a ARE ETHNIC DIFFERENCES IMPORTANT FOR COVID-19? -- HT AND COVID-19 -- MYOCARDIAL INJURY SEVERITY AND MORTALITY -- How Much Myocardial Damage Occurs in COVID-19? -- In Whom Does Myocardial Damage Occur and How Do We Identify It? -- Any Pathological Finding? -- Global View of Myocardial Infarction (STEMI / NSTEMI) After COVID-19 -- Did The Pandemic Affect Heart Attacks? -- What Should Be Done? -- COVID-19 and Myocardial Damage, Myocarditis -- Fulminant Myocarditis (FM) -- Symptoms and Signs in Myocarditis -- Ancillary Studies -- THROMBOTIC EVENTS, BLEEDING, COAGULOPATHIES, AND COVID-19 -- Cytokine-Mediated Alveolar Inflammation Triggers the Formation Of Microthrombi In The Pulmonary Vasculature, Which Can Culminate Into Thrombi Or Embolism In Severe Cases -- Increased D-dimer, PT, aPTT, CRP, ESR, and PCT Levels Noted on Presentation were Found To Be Associated With Death In Covid-19 Patients (Al-Samkari and others, 2020) -- Additional Note: Mean Values Of Fibrinogen, Ferritin, Pct Are Also Higher In Patients With Thrombosis -- Pathological Mechanism -- CONCLUSION -- REFERENCES -- Gastrointestinal Signs and Symptoms in the Course of COVID-19 -- INTRODUCTION -- HOW IMPORTANT IS GIS IN THE PATHOPHYSIOLOGY OF THE VIRUS? -- Which GI Findings Do We Mention About? -- Children and GI Complaints -- Inflammatory Bowel Diseases (IBD) and COVID-19 -- Hepatic Damage and COVID-19 -- CONCLUSION -- REFERENCES -- Is Our Psychology Affected By the Pandemic? How? -- WHAT ARE STRESS REACTIONS? WHAT CAN WE DO? -- WHY ARE WE STRESSED DURING THIS PERIOD? -- ADVERSE EMOTIONAL, PHYSICAL, OR COGNITIVE RESPONSES THAT ARISE IN RESPONSE TO THE EFFECTS OF THE COVID-19 PANDEMIC INCLUDE -- COVID-19 and our Psychology: What do the Researchers Say? -- COVID-19 and Dealing with Stress -- Coping with Stress -- Awareness of Emotions -- Social Relations.
|
| 505 |
8 |
|
|a Try not to Disturb your Routine and Sleep Patterns -- Do Hobbies Work? -- What Does Physical Activity Bring us? -- Bias and Stigmatization -- CONCLUSION -- REFERENCES -- COVID-19 and Our Brain: What's New? -- INTRODUCTION -- HOW CAN COVID-19 AFFECT THE BRAIN AND NERVOUS SYSTEM? -- WHAT KIND OF DAMAGE DOES COVID-19 CAUSE IN THE BRAIN? -- WHAT KINDS OF NEUROLOGICAL SIGNS AND SYMPTOMS DO COVID-19 CAN BE EVIDENT? -- DOES IT HAVE LONG-TERM EFFECTS ON THE CNS? -- EFFECTS OF COVID-19 ON PEOPLE WITH NEUROLOGICAL DISORDERS -- DOES COVID-19 INCREASE THE RISK OF STROKE? -- MANY PATIENTS MENTION LOSS OF SMELL / TASTE -- IS THERE AN ASSOCIATION BETWEEN ANOSMIA AND RESPIRATORY FAILURE? -- DOES COVID-19 TRIGGER BRAIN TISSUE INFLAMMATION (ENCEPHALITIS)? -- WHAT ARE THE TREATMENT METHODS AFTER COVID-19 INFLICTS THE CNS? -- CONCLUSION -- REFERENCES -- COVID-19 Pneumonia and ARDS: The Real Killer? -- DEFINITION -- CLINICAL FEATURES -- DIAGNOSIS -- THE MOST COMMON CT FINDINGS ON PRESENTATION (ADAPTED FROM PAN ET AL, 2020) -- DIFFERENTIAL DIAGNOSES -- OTHER SITUATIONS TO BE DISTINGUISHED -- SERUM ANTIBODY DETECTION -- LABORATORY FINDINGS -- RISK FACTORS FOR SEVERE DISEASE -- ARDS -- Treatment of Pneumonia and ARDS -- Hypoxia Management in Severe and Critical COVID-19 Patient -- Specific Drug Treatments -- CONCLUSION -- REFERENCES -- Pregnancy, COVID-19, and Children: Dangerous Trio? -- WHAT ARE THE CHARACTERISTICS OF PREGNANT WOMEN WITH COVID-19? -- Should there be a Different Warning for Pregnant Healthcare Workers? -- Could the Pregnant Women with Covid-19 Transmit the Disease to the Baby? -- How is Protection from Covid-19 during Pregnancy? -- What are the General Treatment Methods in Pregnant Women? -- Are the Drugs used in the Treatment of Covid-19 Harmful during Pregnancy? -- Can the Woman with COVID-19 Breastfeed her Baby?.
|
| 590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
| 650 |
|
0 |
|a COVID-19 (Disease)
|
| 650 |
|
2 |
|a COVID-19
|
| 650 |
|
6 |
|a COVID-19.
|
| 650 |
|
7 |
|a COVID-19 (Disease)
|2 fast
|
| 700 |
1 |
|
|a Yeniocak, Selman.
|
| 700 |
1 |
|
|a Hosseinzadeh, Mandana.
|
| 758 |
|
|
|i has work:
|a DEMYSTIFYING COVID-19 (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCYCW7P4FhRwpGVcCgPkbMK
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
| 776 |
0 |
8 |
|i Print version:
|a Karcioglu, Ozgur
|t Demystifying COVID-19: Understanding the Disease, Its Diagnosis. and Treatment
|d Sharjah : Bentham Science Publishers,c2021
|z 9781681087795
|
| 856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=6640409
|z Texto completo
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL6640409
|
| 994 |
|
|
|a 92
|b IZTAP
|
